BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6254514)

  • 1. Differential effects of guanine nucleotides on the first step of VIP and glucagon action in membranes from liver cells.
    Amiranoff B; Laburthe M; Rosselin G
    Biochem Biophys Res Commun; 1980 Sep; 96(1):463-8. PubMed ID: 6254514
    [No Abstract]   [Full Text] [Related]  

  • 2. The glucagon receptor from liver can be functionally fused to caudate nucleus adenylate cyclase.
    Tolkovsky AM; Martin BR
    FEBS Lett; 1982 Dec; 150(2):337-42. PubMed ID: 6297980
    [No Abstract]   [Full Text] [Related]  

  • 3. Guanosine 5'-triphosphate and guanosine 5'-[beta gamma-imido]triphosphate effect a collision coupling mechanism between the glucagon receptor and catalytic unit of adenylate cyclase.
    Houslay MD; Dipple I; Elliott KR
    Biochem J; 1980 Mar; 186(3):649-58. PubMed ID: 6249258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanyl nucleotide regulation of vasoactive intestinal peptide interaction with rat liver membranes.
    Ramírez-Cárdenas R; Prieto JC; Guerrero JM; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):9-16. PubMed ID: 6264553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupling of glucagon receptor to adenylyl cyclase. Requirement of a receptor-related guanyl nucleotide binding site for coupling of receptor to the enzyme.
    Iyengar R; Swartz TL; Birnbaumer L
    J Biol Chem; 1979 Feb; 254(4):1119-23. PubMed ID: 216687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for distinct guanine nucleotide sites in the regulation of the glucagon receptor and of adenylate cyclase activity.
    Lad PM; Welton AF; Rodbell M
    J Biol Chem; 1977 Sep; 252(17):5942-6. PubMed ID: 197077
    [No Abstract]   [Full Text] [Related]  

  • 7. VIP activation of rat anterior pituitary adenylate cyclase.
    Robberecht P; Deschodt-Lanckman M; Camus JC; de Neef P; Lambert M; Christophe J
    FEBS Lett; 1979 Jul; 103(2):229-33. PubMed ID: 467664
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of VIP-sensitive adenylate cyclase in guinea pig brain.
    Deschodt-Lanckman M; Robberecht P; Christophe J
    FEBS Lett; 1977 Nov; 83(1):76-80. PubMed ID: 923825
    [No Abstract]   [Full Text] [Related]  

  • 9. The hepatic angiotensin II receptor. II. Effect of guanine nucleotides and interaction with cyclic AMP production.
    Crane JK; Campanile CP; Garrison JC
    J Biol Chem; 1982 May; 257(9):4959-65. PubMed ID: 6279654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone receptor modulates the regulatory component of adenylyl cyclase by reducing its requirement for Mg2+ and enhancing its extent of activation by guanine nucleotides.
    Iyengar R; Birnbaumer L
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5179-83. PubMed ID: 6291028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient complexes. A new structural model for the activation of adenylate cyclase by hormone receptors (guanine nucleotides/irradiation inactivation).
    Martin BR; Stein JM; Kennedy EL; Doberska CA; Metcalfe JC
    Biochem J; 1979 Nov; 184(2):253-60. PubMed ID: 230831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation by guanine nucleotides of the VIP-induced adenylate cyclase stimulation in intestinal epithelial cell membranes.
    Amiranoff B; Laburthe M; Rosselin G
    Life Sci; 1980 Jun; 26(22):1905-11. PubMed ID: 7401908
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of freezing on the coupling of VIP receptors to adenylate cyclase in rat liver membranes.
    Robberecht P; Waelbroeck M; De Neef P; Camus JC; Gourlet P; Christophe J
    Life Sci; 1988; 42(5):505-10. PubMed ID: 2828794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanine nucleotide regulation of VIP binding to rat peritoneal macrophage membranes.
    Segura JJ; Guerrero JM; Goberna R; Calvo JR
    Peptides; 1992; 13(5):953-5. PubMed ID: 1480518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vasoactive intestinal peptide (VIP): specific receptors and adenylate cyclase activation in a human prolactin-secreting pituitary tumor].
    Bataille D; Peillon F; Besson J; Rosselin G
    C R Seances Acad Sci D; 1979 May; 288(17):1315-7. PubMed ID: 225051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of guanyl nucleotides on follitropin-dependent adenylate cyclase in the testis.
    Maghun-Rogister G; Hennen G
    FEBS Lett; 1979 Apr; 100(1):121-4. PubMed ID: 437093
    [No Abstract]   [Full Text] [Related]  

  • 17. Hormone receptor-mediated stimulation of adenylyl cyclase systems. Nucleotide effects and analysis in terms of a simple two-state model for the basic receptor-affected enzyme.
    Iyengar R; Abramowitz J; Bordelon-Riser M; Birnbaumer L
    J Biol Chem; 1980 Apr; 255(8):3558-64. PubMed ID: 6245083
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics of the guanine nucleotide-binding regulatory component of adenylate cyclase.
    Smigel MD; Northup JK; Gilman AG
    Recent Prog Horm Res; 1982; 38():601-24. PubMed ID: 6289396
    [No Abstract]   [Full Text] [Related]  

  • 19. Secretin receptors on neuroblastoma cell membranes: characterization of 125I-labeled secretin binding and association with adenylate cyclase.
    Roth BL; Beinfeld MC; Howlett AC
    J Neurochem; 1984 Apr; 42(4):1145-52. PubMed ID: 6321661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of guanyl nucleotides toward adenylate cyclase activity of Chinese hamster ovary cell membranes activated in vitro by cholera toxin.
    Evain D; Anderson WB
    J Biol Chem; 1979 Sep; 254(18):8726-9. PubMed ID: 479151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.